Liver Fibrosis: From Pathogenesis to Novel Therapies

Publisher： Karger

E-ISSN： 1421-9875|34|4|410-422

ISSN： 0257-2753

Source： Digestive Diseases, Vol.34, Iss.4, 2016-05, pp. : 410-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Therapies for Liver Fibrosis

By  

Digestive Diseases, Vol. 24, Iss. 1-2, 2006-05 ,pp. : 174-183

Karger

Access to resources Recommend Favorite

The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B

By Shindo Michiko   Hamada Kazushige   Nishioji Kenichi   Muramatsu Akira   Oda Yoko   Okuno Tadao  

Journal of Gastroenterology, Vol. 39, Iss. 3, 2004-03 ,pp. : 260-267

Springer Publishing Company

Access to resources Recommend Favorite

Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies

By  

Digestive Diseases, Vol. 35, Iss. 4, 2017-05 ,pp. : 310-313

Karger

Access to resources Recommend Favorite

Hepatic Fibrosis: Emerging Therapies

By  

Digestive Diseases, Vol. 33, Iss. 4, 2015-07 ,pp. : 504-507

Karger

Access to resources Recommend Favorite

Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies

By  

Digestive Diseases, Vol. 34, Iss. 4, 2016-05 ,pp. : 356-363

Karger

Access to resources Recommend Favorite